Search
for
Sort by
Research 30 of 1000+
- Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
- A case of extensive alopecia areata following Pfizer‐BioNTech BNT162b2 mRNA COVID‐19 vaccine with favorable outcome
- Alopecia Areata after COVID-19 Vaccines
- A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis after the Administration of a Heterologous COVID-19 Vaccine Scheme
- Medication-induced hair loss: An update
- Side Effects of COVID-19 Vaccination Among Medical Students in Bangladesh: A Cross-Sectional Study
- Marie Antoinette syndrome following COVID‐19 vaccination
- A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS‐CoV‐2 vaccine
- Bacillus Calmette-Guerin (BCG) Site Reaction After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination
- Transverse Leukonychia and Beau Lines Following COVID-19 Vaccination
- COVID-19: The question of genetic diversity and therapeutic intervention approaches
- COVID-19 Infection and Vaccination Effects on Breast Implant Illness: A Case Report
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
- How coronavirus disease 2019 vaccination affect the level of vitamin D in serum and hair?
- Alopecia Areata Possibly Secondary to COVID-19 Vaccine
- Alopecia areata following COVID-19 vaccine: a systematic review
- A clinical case of a patient with mucocutaneous and musculoskeletal manifestations after COVID-19 vaccination
- EU Legal and Regulatory Update
- Association of alopecia areata with COVID-19 vaccination: A vaccine adverse events reporting system analysis
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- Spectrum of Mucocutaneous Reactions to COVID-19 Vaccination: A Report from a Web-Based Study from India.
- Post‐COVID-19 syndrome: assessment of short- and long-term post-recovery symptoms in recovered cases in Saudi Arabia
- Clinical Manifestation of Alopecia Areata After COVID-19 Infection or Vaccination
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- Prenatal Androgenization of Ewes as a Model of Hirsutism in Polycystic Ovary Syndrome
- Filaggrin mutations as an archetype for understanding the pathophysiology of atopic dermatitis
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- THE COVID- 19 VACCINATION: AUTOIMMUNE PHENOMENON ALOPECIA AREATA
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial